FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3023478404> ?p ?o ?g. }

• W3023478404 endingPage "2000110" @default.
• W3023478404 startingPage "2000110" @default.
• W3023478404 abstract "Significant advances have been made in the development of nanoparticles for cancer treatment in recent years. Despite promising results in preclinical animal models, cancer nanomedicines often fail in clinical trials. This failure rate could be reduced by defining stringent criteria for testing and quality control during the design and development stages, and by performing carefully planned preclinical studies in relevant animal models. This article discusses best practices for the evaluation of nanomedicines in murine tumor models. First, a recommended set of experiments to perform is introduced, including discussion of the types of data to collect during these studies. This is followed by an outline of various tumor models and their clinical relevance. Next, different routes of nanoparticle administration are overviewed, followed by a summary of important controls to include in in vivo studies of nanomedicine. Finally, animal welfare considerations are discussed, and an overview of the steps involved in achieving US Food and Drug Administration approval after animal studies are completed is provided. Researchers should use this report as a guideline for effective preclinical evaluation of cancer nanomedicine. As the community adopts best practices for in vivo testing, the rate of clinical translation of cancer nanomedicines is likely to improve." @default.
• W3023478404 created "2020-05-13" @default.
• W3023478404 creator A5000305243 @default.
• W3023478404 creator A5009466065 @default.
• W3023478404 creator A5011058867 @default.
• W3023478404 creator A5012536029 @default.
• W3023478404 creator A5042372768 @default.
• W3023478404 date "2020-05-04" @default.
• W3023478404 modified "2023-10-18" @default.
• W3023478404 title "Best Practices for Preclinical In Vivo Testing of Cancer Nanomedicines" @default.
• W3023478404 cites W1409374736 @default.
• W3023478404 cites W1551407310 @default.
• W3023478404 cites W1685085476 @default.
• W3023478404 cites W180123612 @default.
• W3023478404 cites W1966657242 @default.
• W3023478404 cites W1980361000 @default.
• W3023478404 cites W1981851742 @default.
• W3023478404 cites W1982106711 @default.
• W3023478404 cites W1992303404 @default.
• W3023478404 cites W1996398553 @default.
• W3023478404 cites W1998773364 @default.
• W3023478404 cites W2015187541 @default.
• W3023478404 cites W2020469175 @default.
• W3023478404 cites W2027117428 @default.
• W3023478404 cites W2034347338 @default.
• W3023478404 cites W2052538292 @default.
• W3023478404 cites W2064771907 @default.
• W3023478404 cites W2068164877 @default.
• W3023478404 cites W2070159291 @default.
• W3023478404 cites W2072301209 @default.
• W3023478404 cites W2074729812 @default.
• W3023478404 cites W2080998956 @default.
• W3023478404 cites W2091869463 @default.
• W3023478404 cites W2094214288 @default.
• W3023478404 cites W2108447763 @default.
• W3023478404 cites W2115785123 @default.
• W3023478404 cites W2117415427 @default.
• W3023478404 cites W2117692326 @default.
• W3023478404 cites W2117981139 @default.
• W3023478404 cites W2136632899 @default.
• W3023478404 cites W2151734986 @default.
• W3023478404 cites W2162755712 @default.
• W3023478404 cites W2176728142 @default.
• W3023478404 cites W2281655571 @default.
• W3023478404 cites W2321337839 @default.
• W3023478404 cites W2512135057 @default.
• W3023478404 cites W2515800095 @default.
• W3023478404 cites W2518686043 @default.
• W3023478404 cites W2562352619 @default.
• W3023478404 cites W2563661701 @default.
• W3023478404 cites W2605267422 @default.
• W3023478404 cites W27417234 @default.
• W3023478404 cites W2751023845 @default.
• W3023478404 cites W2766673373 @default.
• W3023478404 cites W2804152562 @default.
• W3023478404 cites W2889274053 @default.
• W3023478404 cites W2897422388 @default.
• W3023478404 cites W2903444830 @default.
• W3023478404 cites W2907979437 @default.
• W3023478404 cites W2918684851 @default.
• W3023478404 cites W2936221687 @default.
• W3023478404 cites W2947989483 @default.
• W3023478404 cites W2952789136 @default.
• W3023478404 cites W2955556244 @default.
• W3023478404 cites W2969908486 @default.
• W3023478404 cites W989479261 @default.
• W3023478404 doi "https://doi.org/10.1002/adhm.202000110" @default.
• W3023478404 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7473451" @default.
• W3023478404 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32367687" @default.
• W3023478404 hasPublicationYear "2020" @default.
• W3023478404 type Work @default.
• W3023478404 sameAs 3023478404 @default.
• W3023478404 citedByCount "12" @default.
• W3023478404 countsByYear W30234784042020 @default.
• W3023478404 countsByYear W30234784042021 @default.
• W3023478404 countsByYear W30234784042022 @default.
• W3023478404 countsByYear W30234784042023 @default.
• W3023478404 crossrefType "journal-article" @default.
• W3023478404 hasAuthorship W3023478404A5000305243 @default.
• W3023478404 hasAuthorship W3023478404A5009466065 @default.
• W3023478404 hasAuthorship W3023478404A5011058867 @default.
• W3023478404 hasAuthorship W3023478404A5012536029 @default.
• W3023478404 hasAuthorship W3023478404A5042372768 @default.
• W3023478404 hasBestOaLocation W30234784042 @default.
• W3023478404 hasConcept C112930515 @default.
• W3023478404 hasConcept C121608353 @default.
• W3023478404 hasConcept C126322002 @default.
• W3023478404 hasConcept C142724271 @default.
• W3023478404 hasConcept C15083742 @default.
• W3023478404 hasConcept C155672457 @default.
• W3023478404 hasConcept C171250308 @default.
• W3023478404 hasConcept C192562407 @default.
• W3023478404 hasConcept C19527891 @default.
• W3023478404 hasConcept C2780182762 @default.
• W3023478404 hasConcept C2993043200 @default.
• W3023478404 hasConcept C535046627 @default.
• W3023478404 hasConcept C71924100 @default.
• W3023478404 hasConceptScore W3023478404C112930515 @default.

• next